Search for: "ACTAVIS"
Results 201 - 220
of 1,005
Sort by Relevance
|
Sort by Date
15 Nov 2018, 10:21 am
Warren-Lambert claimed Mylan and Actavis infringed on Warren-Lambert’s patent, as it was applied for treatment against neurotic pain. [read post]
14 Nov 2018, 3:25 am
Actavis manufactures Lecaent, a pregabalin generic. [read post]
24 Oct 2018, 3:49 am
Lord Kitchin called these the "Actavis questions". [read post]
17 Oct 2018, 8:28 am
The Court therefore gave consideration to what Lord Kitchin denoted the “Actavis questions” further to the Supreme Court decision in Actavis v Eli Lilly. [read post]
19 Sep 2018, 11:28 am
Actavis[18] and concurring in California Dental Association v. [read post]
18 Sep 2018, 2:23 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
17 Sep 2018, 6:48 am
Current drugs subject to recall include: Tablets sold by firms AvKare (Teva/Actavis) and (Hetero/Camber), A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco), Bryant Ranch Prepack Inc, (Teva/Actavis), Hetero Labs (labeled as Camber Pharmaceuticals Inc.), H J Harkins Co., Northwind Pharmaceuticals (Teva/Actavis), NuCare Pharmaceuticals Inc. [read post]
16 Sep 2018, 9:02 pm
Actavis Elizabeth LLC handed down earlier this month. [read post]
6 Sep 2018, 5:38 pm
The Actavis decision also doesnot color our decision-making on appeal. [read post]
3 Aug 2018, 8:22 am
Highlights this week include a one-year-on perspective of Actavis v Eli Lilly, further news on the progress of the DSM Directive and an update on the governance issues of the Collecting Society of Nigeria (COSON).PatentsThe Kluwer Patent Blog marks the first year anniversary of the landmark Supreme Court decision Actavis v Eli Lilly: Actavis and Equivalents – One Year On. [read post]
31 Jul 2018, 7:58 am
In the decision leading to the referral, Justice Arnold considered that the answers previously given by the CJEU on the interpretation of Article 3 (a) in Medeva, Actavis v Sanofi and Lilly were not sufficiently clear and therefore asked question 1 in Actavis v Sanofi again: “What are the criteria for deciding whether ‘the product is protected by a basic patent in force’ in Article 3(a) of the SPC Regulation? [read post]
20 Jul 2018, 8:45 am
Carrier, Rutgers Law School describes The Rule of Reason in the Post-Actavis World. [read post]
12 Jul 2018, 6:19 am
Validity was not in issue in Actavis and so the topic was not addressed. [read post]
3 Jul 2018, 10:21 am
More from our authors: Mediation: Creating Value in International Intellectual Property Disputes by Théophile Margellos, Sophia Bonne, Gordon Humphreys, Sven Stürmann € The post Actavis UK Limited v Eli Lilly, Supreme Court of the United Kingdom, [2017] UKSC 48, 12 July 2017 appeared first on Kluwer Patent Blog. [read post]
28 Jun 2018, 2:45 am
Sara MoranFollowing its denial of Actavis’ claim for declarations of non-infringement in respect of Eli Lilly’s European Patent, the Court of Appeal ruled on a number of procedural matters arising from that judgment. [read post]
27 Jun 2018, 7:24 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
25 Jun 2018, 7:15 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
22 Jun 2018, 3:18 am
Actavis | Can YouTube be primarily liable for users' infringements? [read post]
20 Jun 2018, 4:12 am
C-322/10 – Medeva, C-518/10 – Yeda, C-630/10 – University of Queensland, C-6/11 – Daiichi Sankyo, C-493/12 – Eli Lilly, and C-443/12 – Actavis/Sanofi) and came to the conclusion that the requirements of Article 3(a) of the EU SPC-Regulation No 469/2009, i.e. whether the product of an SPC is protected by the basic patent, are unclear and, therefore, there was no reason to move away from the infringement test. [read post]
18 Jun 2018, 5:30 am
Actavis. [read post]
